What happens when a clinical trial fails to comply with regulations? Fines, delays, and loss of credibility are just the tip of the iceberg. In a sector where patient safety and scientific integrity a...
Outsourcing analytical development, more than a cost-saving mechanism, has become a strategic lever that shapes data quality, regulatory confidence, and development speed. When aligned correctly, anal...
A multi‑country oncology study regained momentum through structured transition planning, seamless cross‑functional collaboration and decisive operational oversight, regulatory recovery, and discip...
Las crisis no deben paralizar la investigación, pero tampoco justificar atajos que pongan en riesgo a los participantes o la validez de los resultados. Este es el leit motiv de la nueva guía de la E...
How sponsors can leverage both the EU Clinical Trials Regulation and UK’s reformed framework to achieve cost efficiencies, faster timelines, and stronger regulatory positioning.
In the day-to-day conduct of clinical trials, one of the factors that most strongly affects patient recruitment and retention is not the scientific design of the protocol, but rather the indirect fina...